The severity , frequency , and complications of TB IRIS were evaluated in A5221 , a randomized trial of earlier ART ( within 2 weeks after TB treatment initiation ) vs. later ART ( 8-12 weeks after TB treatment ) in HIV-infected patients starting TB treatment .